Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Class A Common Stock, Par Value $.0001
Symbol
RANI on Nasdaq
Shares outstanding
98,437,808
Price per share
$1.28
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
44,799,019
Total reported value
$60,478,537
% of total 13F portfolios
0%
Share change
+34,730,267
Value change
+$47,505,485
Number of holders
61
Price from insider filings
$1.28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
InCube Labs, L.L.C. 22% $13,541,357 27,093,552 MIR A IMRAN 23 Oct 2025
Samsara BioCapital, L.P. 9.9% $4,939,262 9,882,477 Srinivas Akkaraju 23 Oct 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $4,939,262 9,882,477 RA Capital Management, L.P. 23 Oct 2025
Invus Global Management, LLC 10% $4,910,990 9,825,911 Raymond Debbane 16 Oct 2025
AWM Investment Company, Inc. 9.9% $14,520,561 9,745,343 AWM Investment Company, Inc. 31 Dec 2025
ARMISTICE CAPITAL, LLC 9.9% $4,131,600 6,260,000 Armistice Capital, LLC 30 Jun 2025
VANGUARD GROUP INC 5.2% $6,897,647 5,109,368 The Vanguard Group 31 Dec 2025
South Cone Investments Limited Partnership 4.9% $1,189,121 2,379,194 South Cone Investments Limited Partnership 20 Oct 2025
Orca Capital AG 4.3% -56% $972,105 -$1,265,416 1,891,623 -57% Orca Capital AG 22 Jul 2025

As of 31 Dec 2025, 61 institutional investors reported holding 44,799,019 shares of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI). This represents 46% of the company’s total 98,437,808 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) together control 45% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RA CAPITAL MANAGEMENT, L.P. 8.6% 8,500,000 0.12% $11,475,000
SAMSARA BIOCAPITAL, LLC 8.6% 8,500,000 1.2% $11,475,000
AWM Investment Company, Inc. 6.6% 6,500,000 0.85% $8,775,000
SymBiosis Capital Partners, LLC 6.4% 6,300,000 0% 8.8% $8,505,000
VANGUARD GROUP INC 5.2% 5,109,368 +478% 0% $6,897,647
Longaeva Partners L.P. 2.1% 2,113,435 0.34% $2,853,137
Siren, L.L.C. 2% 2,000,000 0.08% $2,700,000
GEODE CAPITAL MANAGEMENT, LLC 0.87% 860,941 +190% 0% $1,162,636
BlackRock, Inc. 0.54% 527,712 +339% 0% $712,412
Nan Fung Group Holdings Ltd 0.5% 493,584 0% 0.6% $666,338
683 Capital Management, LLC 0.49% 487,168 0.05% $657,677
STATE STREET CORP 0.39% 387,042 +520% 0% $522,507
Squarepoint Ops LLC 0.35% 344,378 0% $464,910
UNITED SERVICES AUTOMOBILE ASSOCIATION 0.31% 302,743 0% 0.03% $408,703
GOLDMAN SACHS GROUP INC 0.29% 285,832 0% $385,873
KESTRA PRIVATE WEALTH SERVICES, LLC 0.26% 254,812 +13% 0% $343,996
NORTHERN TRUST CORP 0.17% 170,471 +76% 0% $230,136
MILLENNIUM MANAGEMENT LLC 0.17% 163,300 0% $220,455
UBS Group AG 0.15% 151,523 +119% 0% $204,556
CWA Asset Management Group, LLC 0.15% 150,000 0% 0.01% $202,500
Qube Research & Technologies Ltd 0.15% 148,226 0% $200,105
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.12% 114,500 0% $154,575
FARALLON CAPITAL MANAGEMENT LLC 0.08% 78,000 0% $105,300
OMERS ADMINISTRATION Corp 0.07% 69,200 0% $93,420
KING LUTHER CAPITAL MANAGEMENT CORP 0.06% 58,000 0% 0% $78,300

Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 44,799,019 $60,478,537 +$47,505,485 $1.35 61
2025 Q3 4,033,213 $2,015,817 -$1,258,453 $0.50 36
2025 Q2 6,458,632 $3,319,783 +$1,060,111 $0.51 38
2025 Q1 3,609,389 $4,577,211 -$332,797 $1.26 38
2024 Q4 3,819,967 $5,233,595 -$4,950,047 $1.37 42
2024 Q3 5,911,071 $12,767,865 +$5,999,502 $2.16 31
2024 Q2 3,108,475 $11,809,884 -$1,252,441 $3.80 33
2024 Q1 3,453,784 $10,741,251 +$509,498 $3.11 35
2023 Q4 3,290,303 $10,923,496 -$819,783 $3.32 33
2023 Q3 3,207,291 $6,961,738 -$151,646 $2.18 32
2023 Q2 3,227,286 $13,256,941 +$994,179 $4.12 34
2023 Q1 2,999,366 $15,475,095 +$204,634 $5.16 35
2022 Q4 2,885,407 $17,024,416 -$1,472,942 $5.90 32
2022 Q3 3,174,344 $30,405,447 +$3,581,808 $9.58 30
2022 Q2 2,824,819 $29,094,000 +$2,769,956 $10.33 27
2022 Q1 2,556,816 $34,515,000 +$17,568,047 $13.50 23
2021 Q4 1,240,919 $20,288,000 +$544,189 $16.35 21
2021 Q3 1,097,698 $19,562,000 +$19,562,000 $17.82 14